Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells

Laboratory Investigation

Volumn 77, Issue 1, 1997, Pages 51-61

  Castle, Valerie P ^a   Dixit, Vishva M ^a   Polverini, Peter J ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER; CANCER INHIBITION; CELL STRAIN; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

3T3 CELLS; ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; MUTAGENESIS, SITE-DIRECTED; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENE PROTEIN PP60(V-SRC); RATS; STRUCTURE-ACTIVITY RELATIONSHIP; THROMBOSPONDINS;

EID: 0030751884     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Borstein P and Sage EH (1994). Thrombospondins. Methods Enzymol 245:62-85.
2. Bouck N, Stelimach V, and Hsu S (1996). How tumors become angiogenic. Adv Cancer Res 69:135-174.
3. Castle V, Varani J, Fligiel E, Prochownik V, and Dixit V (1991). Antisense mediated reduction in thrombospondin reverses the malignant phenotype of human squamous carcinoma. J Clin Invest 87:1883-1888.
4. Castle VP, Ou X, O'Rourke K, and Dixit VM (1993). High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum- and anchorage-independent growth. J Biol Chem 268:2899-2903.
5. Chen ZS, Caughman SW, Lawley TJ, and Swerlick RA (1996). Angiogenic factors decrease thrombospondin-1 expression in dermal microvascular endothelial cells. J Invest Dermatol 106:823A.
6. Dameron KM, Volpert OV, Tainsky MA, and Bouck N (1994). Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584.
7. DiPietro LA, Nebgen DR, and Polverini PJ (1994). Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res 31:178-185.
8. Dixit VM, Galvin NJ, O'Rourke KM, and Frazier WA (1986). Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin: Characterization and mapping of their epitopes. J Biol Chem 261:1962-1968.
9. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, and Danielsen M (1987). Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413-7417.
10. Folkman J, Watson K, Ingber D, and Hanahan D (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61.
11. Frazier WA (1987). Thrombospondin: A modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol 105:625-632.
12. Fuhlbrigge RC, Fine SM, Unanue ER, and Chaplin DD (1988). Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc Natl Acad Sci USA 85:5649-5653.
13. Good DJ, Polverini PJ, Rastinejad F, LeBeau, Lemons RS, Frazier WA, and Bouck NP (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628.
14. Goundis D and Reid KB (1988). Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature 335:82-85.
15. Hanahan D, Christofori G, Naik P, and Arbeit J (1996). Transgenic mouse models of tumor angiogenesis: The angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 32A:2386-2393.
16. Hanahan D and Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
17. Iruela-Arispe M, Bornstein P, and Sage H (1991). Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88: 5026-5030.
18. Klar A, Baldassare M, and Jessell TM (1992). F-spondin: A gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension. Cell 69:95-110.
19. Leung-Hagesteijn C, Spence AM, Stern BD, Zhou Y, Su MW, Hedgecock EM, and Culotti JG (1992). UNC-5, a transmembrane protein with immunoglobulin and thrombospondin type 1 domains, guides cell and pioneer axon migrations in C. elegans. Cell 71:289-299.
20. Majack RA, Goodman LV, and Dixit VM (1988). Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol 106:415-422.
21. Majack RA, Mildbrandt J, and Dixit VM (1987). Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Cell Biol 262:8821-8825.
22. Michaud M and Poyet P (1994). Control of the expression of thrombospondin 1 in human breast cancer cell lines. Anticancer Res 14:1127-1131.
23. Nathan FE, Hernandez E, Dunton CJ, Treat J, Switalska HI, Joseph RR, and Tuszynski GP (1994). Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer 73:2853-2858.
24. O'Shea KS and Dixit VM (1988). Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 107:2737-2748.
25. Polverini PJ (1996). How the extracellular matrix and macrophages contribute to angiogenesis and vasoproliferative dependent diseases. Eur J Cancer 32A:2430-2437.
26. Prochownik EV, O'Rourke K, and Dixit VM (1989). Expression and analysis of COOH-terminal deletions of the human thrombospondin molecule. J Cell Biol 109:843-852.
27. Rastinejad F, Polverini PJ, and Bouck NP (1989). Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355.
28. Robson KJ, Hall JR, Jennings MW, Harria TJ, Marsh K, Newbold CI, Tate VE, and Weatherall DJ (1988). A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335:79-82.
29. Sage H and Bornstein P (1982). Endothelial cells from umbilical vein and a hemangioendothelioma secrete basement membrane largely to the exclusion of interstitial procollagens. Ateriosclerosis 2:27-36.
30. Sage H and Bornstein P (1991). Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 266:14831-14834.
31. Salnikow K, Cosentino S, Klein C, and Costa M (1994). Loss of thrombospondin transcriptional activity in nickel-transformed cells. Mol Cell Biol 14:851-858.
32. Sheibani N and Frazier WA (1995). Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc Natl Acad Sci USA 92:6788-6792.
33. Slack JL and Bornstein P (1994). Transformation by v-src causes transient induction followed by transcriptional repression of mouse thrombospondin-1. Cell Growth Differ 5:1373-1380.
34. Taraboletti G, Roberts D, Liotta LA, and Giavazzi R (1990). Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J Cell Biol 111:765-772.
35. Tobelem G (1990). Endothelial cell growth: Biology and pharmacology in relation to angiogenesis. Blood Coagul Fibrinolysis 1:703-705.
36. Tolsma SS, Volpert OV, Good DJ, Polverini PJ, and Bouck N (1993). Small peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497-511.
37. Tuszynski GP (1993). The role of thrombospondin in malignancy and tumor cell metastasis. In: Lahav J, editor: Thrombospondin. Boca Raton, FL: CRC Press, 209-225.
38. Tuszynski GP and Nicosia RF (1996). The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays 18:71-76.
39. Volpert OV, Stellmach V, and Bouck N (1995). The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res Treat 36:119-126.
40. Wang TN, Qian XH, Granick MS, Solomon MP, Rothman VL, and Tuszynski GP (1995). The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen. Am J Surg 170:502-505.
41. Weidner N, Semple JP, Welch WR, and Folkman J (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8.
42. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, and Steeg PS (1994). Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54:6504-511.
43. Zabrenetzky V, Harris CC, Steeg PS, and Roberts DD (1994). Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 59:191-195.